Description
TAMILONG 20 TABLET is a highly effective anti-estrogen therapy formulated with Tamoxifen Citrate 20 mg, widely prescribed in the treatment of hormone receptor-positive breast cancer and as a preventive therapy in high-risk patients.
Tamoxifen acts as a Selective Estrogen Receptor Modulator (SERM). It blocks the effects of estrogen in breast tissue by binding to estrogen receptors, thereby slowing or stopping the growth of cancer cells that require estrogen to grow. It is also used to reduce the risk of developing breast cancer in women who are at a higher genetic or clinical risk.
Treatment of estrogen receptor-positive (ER+) breast cancer
Prevention of breast cancer in high-risk populations
Adjuvant therapy in early and advanced breast cancer
Management of ductal carcinoma in situ (DCIS)
Fertility treatments (off-label use, under medical supervision)
Effective first-line therapy for hormone-dependent breast cancer
Reduces risk of recurrence and new tumor formation
Also used in breast cancer prevention strategies
Long-term safety profile with proven clinical efficacy
Manufactured under stringent pharmaceutical standards
Standard adult dose is 20 mg once daily, with or without food
Duration of therapy depends on clinical condition and physician advice
Follow-up and periodic monitoring recommended during treatment
Not recommended during pregnancy or breastfeeding
Regular gynecological and oncological follow-ups are advised
May cause hot flashes, mood changes, or menstrual irregularities
Use with caution in patients with a history of thrombosis or endometrial issues
TAMILONG 20 TABLET is manufactured in WHO-GMP, ISO, and FDA-approved facilities with rigorous quality control protocols. The product undergoes stringent analytical testing to ensure safety, stability, and therapeutic consistency.
BLUEPILL EXPRESS is a globally recognized third-party pharmaceutical manufacturer and exporter of high-quality medicines, including anti-cancer, cardiovascular, hormonal, and general health formulations. We serve markets across:
Asia
Africa
CIS countries
Europe
Latin America
Middle East

